QG
QGAI
Quantum Genesis AI Corp.
$0.0801
-42.79%
No data for this timeframe.
Vol
SEC Reports4
Recent Activity
Apr 15, 2026
SEC
Quantum Genesis AI Corp. filed an amended 10-Q/A solely to update disclosures in Management's Discussion and Analysis re
10-Q/A — Impact 3/10
Apr 15, 2026
SEC
Quantum Genesis AI Corp. filed an amended 10-Q/A solely to add disclosure about intellectual property formalization via
10-Q/A — Impact 3/10
Apr 15, 2026
SEC
Quantum Genesis AI Corp. (formerly Quantumzyme Corp.) filed an amended 10-K/A to clarify intellectual property ownership
10-K/A — Impact 5/10
Latest Reports
NEUTRAL
10-Q/A
3/10
Quantum Genesis AI Corp. filed an amended 10-Q/A solely to update disclosures in Management's Discussion and Analysis re
Apr 15, 2026
NEUTRAL
10-Q/A
3/10
Quantum Genesis AI Corp. filed an amended 10-Q/A solely to add disclosure about intellectual property formalization via
Apr 15, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 4 neutral. Avg impact: 3.5/10.
NEUTRAL
10-Q/A
3/10
Quantum Genesis AI Corp. filed an amended 10-Q/A solely to update disclosures in Management's Discus
Apr 15, 2026
NEUTRAL
10-Q/A
3/10
Quantum Genesis AI Corp. filed an amended 10-Q/A solely to add disclosure about intellectual propert
Apr 15, 2026
NEUTRAL
10-K/A
5/10
Quantum Genesis AI Corp. (formerly Quantumzyme Corp.) filed an amended 10-K/A to clarify intellectua
Apr 15, 2026
NEUTRAL
8-K
3/10
Quantum Genesis AI Corp. filed a confirmatory Intellectual Property Assignment Agreement to formaliz
Apr 15, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.